公开(公告)号：US20130116526A1

公开(公告)日：2013-05-09

申请号：US13293046

申请日：2011-11-09

Applicant: Jonathan C. Javitt ,  David Bjork ,  John R. Dwyer, JR. ,  Eric Michael Link ,  Kevin Lee McMahon

Inventor： Jonathan C. Javitt ,  David Bjork ,  John R. Dwyer, JR. ,  Eric Michael Link ,  Kevin Lee McMahon

IPC: A61B5/145 ,  G06Q50/22

CPC classification number: G01N27/3273 ,  A61B5/0022 ,  A61B5/14532 ,  A61B5/150022 ,  A61B5/150358 ,  A61B5/150793 ,  A61B5/150854 ,  A61B5/7435 ,  A61B5/7465 ,  A61B2560/0252 ,  A61B2560/0266 ,  A61B2562/182 ,  G01N27/3274 ,  G01N33/48792 ,  G06F19/3418 ,  G16H10/40 ,  G16H10/60 ,  G16H50/20 ,  H04B1/3833

Abstract: A patient monitoring network pertaining to blood glucose and other analyte measurements includes wireless blood glucose or other analyte measuring devices and a networked computer or server. Each monitoring device is associated with a patient and is configured to measure the glucose level or other analyte from a given blood sample via inserted test strips, transmit the measurements to the networked computer, and display received messages. The messages may relate to the current or past measurements, or may include an alert prompting the user of the monitoring device to order more supplies, such as test strips. The measurements received by the networked computer may be stored in a record of a database, which may be accessed by a remote computer. The remote computer may also access a script editor to edit certain scripts which produce certain messages sent to the monitoring device.

Abstract translation: 与血糖和其他分析物测量有关的患者监测网络包括无线血糖或其它分析物测量装置和联网的计算机或服务器。 每个监测装置与患者相关联，并且被配置成经由插入的测试条测量来自给定血液样本的葡萄糖水平或其他分析物，将测量结果发送到联网计算机，并显示接收到的消息。 消息可以与当前或过去的测量相关，或者可以包括提示监视设备的用户订购更多耗材（例如测试条）的警报。 由联网的计算机接收的测量可以存储在数据库的记录中，数据库的记录可由远程计算机访问。 远程计算机还可以访问脚本编辑器来编辑产生发送到监视设备的某些消息的某些脚本。

公开(公告)号：US5494901A

公开(公告)日：1996-02-27

申请号：US935

申请日：1993-01-05

Applicant: Jonathan C. Javitt ,  Norman B. Javitt ,  Peter McDonnell

Inventor： Jonathan C. Javitt ,  Norman B. Javitt ,  Peter McDonnell

IPC: A61K9/08 ,  A61K9/00 ,  A61K31/41 ,  A61K31/42 ,  A61K31/425 ,  A61K47/40 ,  A61P27/02 ,  A61P27/06 ,  A61K31/715 ,  A61K31/70

CPC classification number: A61K9/0048 ,  A61K31/42 ,  A61K31/425 ,  A61K47/40 ,  Y10S514/912 ,  Y10S514/913 ,  Y10S514/914 ,  Y10S514/915

Abstract: A topical composition comprising an amount of a carbonic anhydrase inhibitor and an amount of .beta.-cyclodextrin derivative effective in increasing the bioavailability of the carbonic anhydrase inhibitor when coadministered topically to the eye.

公开(公告)号：US20130178791A1

公开(公告)日：2013-07-11

申请号：US13345771

申请日：2012-01-09

Applicant: Jonathan C. Javitt

Inventor： Jonathan C. Javitt

IPC: A61M5/168

CPC classification number: A61M5/16827 ,  A61M5/14248 ,  A61M5/1723 ,  A61M2005/14208 ,  A61M2005/14252 ,  A61M2205/3553 ,  A61M2205/50

Abstract: The present invention generally relates to radio-enabled devices for detection and remedy of biological and chemical warfare attack. More particularly, this invention relates to an on-body apparatus that provides a means of treatment which is innocuous to the wearer, but capable of injecting antidotes within seconds and preferably also combines multiple means of sensing chemical and biological agents as well as monitoring user's physiological response to the antidotes thereby to enable tailored and continuous infusion of antidotes while minimizing the side effect of the antidotes themselves. A key embodiment of this invention is the incorporation of an electronically-controlled needle or cannula that will deploy only when commanded to. When not deployed, the device sits inertly against the patient's skin, affixed by adhesive and or elastic materials.

Abstract translation: 本发明一般涉及用于生物和化学战争攻击的检测和补救的无线电装置。 更具体地，本发明涉及一种身体装置，其提供对佩戴者无害的但能够在数秒内注射解毒剂的治疗方法，并且优选地还结合了多种感测化学和生物学试剂的方法以及监测用户的生理 对解毒剂的反应从而能够定制和连续地输注解毒剂，同时尽量减少解毒剂本身的副作用。 本发明的关键实施例是结合电子控制的针或插管，其仅在命令时部署。 当没有部署时，设备会惰性地靠在病人的皮肤上，用粘合剂和/或弹性材料固定。

公开(公告)号：US5918208A

公开(公告)日：1999-06-29

申请号：US422511

申请日：1995-04-13

Applicant: Jonathan C. Javitt

Inventor： Jonathan C. Javitt

IPC: G06Q50/22 ,  G06F159/00 ,  G06F17/60

CPC classification number: G06Q40/08 ,  G06Q50/22

Abstract: A managed care expert system provides a graphical, interactive computer system which accepts user input relating to contract variables for a plurality of alternative contract scenarios, consults a database of national and locality-specific utilization data, performs a utilization and revenue analysis for both commercial and Medicare-age beneficiaries, and provides a synthetic fee schedule for comparing the likely revenue under capitation for a plurality of services to revenue for those services under a current reimbursement scenario. The system of the invention in its preferred embodiment enables a physician or other health care professional to use a broad array of assumptions to forecast utilization of medical procedures and estimated revenue per procedure under multiple capitation scenarios.

公开(公告)号：US20130046281A1

公开(公告)日：2013-02-21

申请号：US13212171

申请日：2011-08-17

Applicant: Jonathan C. Javitt

Inventor： Jonathan C. Javitt

IPC: A61M5/168

CPC classification number: A61M5/1723 ,  A61M5/24 ,  A61M2205/3553 ,  A61M2205/3584 ,  A61M2205/3592 ,  A61M2205/50 ,  A61M2230/201 ,  A61M2230/205 ,  A61M2230/50 ,  A61M2230/63

Abstract: A closed loop infusion formulation delivery system for controlling a biological state in the body of a user includes a sensor for generating a signal representative of measured parameters and a computing element for processing the generated signal. The computing element adjusts control parameters within an algorithm, calculates a delivery rate of an infusion formulation and generates commands based on the calculated delivery rate. A remotely located monitoring station communicates with the computing element via radio or wire to further adjust the control parameters within the algorithm to meet changing needs in the body of the user.

Abstract translation: 用于控制使用者身体中的生物状态的闭环输注制剂输送系统包括用于产生表示测量参数的信号的传感器和用于处理所产生的信号的计算元件。 计算元件调整算法内的控制参数，计算输注配方的传送速率，并根据计算的传送速率生成命令。 远程监控站通过无线电或有线通信与计算元件进一步调整算法内的控制参数，以满足用户体内不断变化的需求。

公开(公告)号：US5418225A

公开(公告)日：1995-05-23

申请号：US935

申请日：1993-01-05

Applicant: Jonathan C. Javitt ,  Norman B. Javitt ,  Peter McDonnell

Inventor： Jonathan C. Javitt ,  Norman B. Javitt ,  Peter McDonnell

IPC: A61K9/08 ,  A61K9/00 ,  A61K31/41 ,  A61K31/42 ,  A61K31/425 ,  A61K47/40 ,  A61P27/02 ,  A61P27/06 ,  A61K31/715 ,  A61K31/70

CPC classification number: A61K9/0048 ,  A61K31/42 ,  A61K31/425 ,  A61K47/40 ,  Y10S514/912 ,  Y10S514/913 ,  Y10S514/914 ,  Y10S514/915

Abstract: A topical composition comprising an amount of a carbonic anhydrase inhibitor and an amount of .beta.-cyclodextrin derivative effective in increasing the bioavailability of the carbonic anhydrase inhibitor when coadministered topically to the eye.

Abstract translation: 一种局部组合物，其包含一定量的碳酸酐酶抑制剂和一定量的β-环糊精衍生物，当局部地局部施用于眼睛时，可有效增加碳酸酐酶抑制剂的生物利用度。